Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Alegret, Josep M ^a   Viñolas, Xavier ^b   Romero Menor, César ^c   Pons, Silvia ^d   Villuendas, Roger ^e   Calvo, Naiara ^f   Pérez Rodon, Jordi ^g   Sabaté, Xavier ^h   Sabate X ⁱ   Serrat, R ^j   Sualis A ^j   Planas, F ^j   Vazquez, G ^k   Escudero, J ^l   Abardia, X ^m   Barbera C ^m   Guillamon, L ⁿ   Mont, L ^o   Calvo, N ^o   Sadurni J ^j   Pons, S ^j   Descalzi, A ^p   Batalla, N ^q   Sanz, E ^r   Serrano, S ^r   Perez Rodon J ^s   Rodriguez Font E ^b   Freire, F ^j   Vilaseca, M ^j   Romero, C ^j   Duran, I ^a   Tomas J ^t   Lechuga, I ^j   Villuendas, R ^u   Jaber, A ^j   Romeo, I ^j   Canals, R ^j   Paz, M ^j   more..

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c PARC SANITARI SANT JOAN DE DÉU   (Spain)

^d Hospital de Niños de Barcelona   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ HU de Bellvitge Hospitalet de Llobregat   (Spain)

^j H del Mar ^*  (Spain)

^k H Comarcal de la Selva   (Spain)

^l HOSPITAL MÚTUA DE TERRASSA   (Spain)

^m Servicio de Radiología   (Spain)

ⁿ H del Parc Taulí   (Spain)

^o Servicio de Enfermedades Autoinmunes H Clinic   (Spain)

^p H Comarcal Alt Penedés   (Spain)

^q HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^r HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^s Fundació Institut Vall d Hebron   (Spain)

^t HU Arnau de Vilanova   (Spain)

^u H Germans Trias i Pujol   (Spain)

more..

Author keywords

Atrial fibrillation; Electrical cardioversion; Follow up; Rate control; Rhythm control

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; COMORBIDITY; DIABETES MELLITUS; EMBOLISM; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SINUS RHYTHM; TERTIARY HEALTH CARE; TREND STUDY; WEIGHT GAIN;

AGE FACTORS; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; COMORBIDITY; ELECTRIC COUNTERSHOCK; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862266690     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-42     Document Type: Article

References (19)

1. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002, 347:1825-1833.
2. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002, 347:1834-1840. 10.1056/NEJMoa021375, 12466507.
3. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. 2006 ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2006, 27(16):1979-2030.
4. Talajic M, Khairy P, Levesque S, Connolly SJ, Dorian P, Dubuc M, Guerra PG, Hohnloser SH, Lee KL, Macle L, Nattel S, Pedersen OD, Stevenson LW, Thibault B, Waldo AL, Wyse DG, Roy D. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol 2010, 55:1796-1802. 10.1016/j.jacc.2010.01.023, 20413028.
5. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomström-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Eur Heart J 2001, 22:1852-1923.
6. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429.
7. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Hear Rhythm 2011, 8:157-176.
8. Mason PK, Wood MA, Lake D, DiMarco JP. Influence of the randomized trials, AFFIRM and RACE, on the management of atrial fibrillation in two university medical centers. Am J Cardiol 2005, 95:1248-1250. 10.1016/j.amjcard.2005.01.059, 15878004.
9. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, . AFFIRM Investigators Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004, 109:1509-1513. AFFIRM Investigators.
10. Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001, 344:1411-1420. 10.1056/NEJM200105103441901, 11346805.
11. Koster RW, Dorian P, Chapman FW, Schmitt PW, O'Grady SG, Walker RG. A randomized trial comparing monophasic and biphasic waveform shocks for external cardioversion of atrial fibrillation. Am Heart J 2004, 147:e20.
12. Scholten M, Szili-Torok T, Klootwijk P, Jordaens L. Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation. Heart 2003, 89:1032-1034. 10.1136/heart.89.9.1032, 1767835, 12923020.
13. Alegret JM, Viñolas X, Sagristá J, Hernandez-Madrid A, Pérez L, Sabaté X, Mont L, Medina A, . the REVERSE Study Investigators Predictors of success and effect of biphasic energy on electrical cardioversion in patients with persistent atrial fibrillation. Europace 2007, 9:942-946. 10.1093/europace/eum107, 17545688, the REVERSE Study Investigators.
14. Guglin M, Maradia K, Chen R, Curtis AB. Relation of obesity to recurrence rate and burden of atrial fibrillation. Am J Cardiol 2011, 107:579-582. 10.1016/j.amjcard.2010.10.018, 21195377.
15. Ueng KC, Tsai TP, Yu WC, Tsai CF, Lin MC, Chan KC, Chen CY, Wu DJ, Lin CS, Chen SA. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J 2003, 24:2090-2098. 10.1016/j.ehj.2003.08.014, 14643269.
16. Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Smith P, Arnesen H. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. Am J Cardiol 2007, 99:1544-1548. 10.1016/j.amjcard.2007.01.030, 17531578.
17. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006, 27:949-953.
18. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009, 104:1534-1539. 10.1016/j.amjcard.2009.07.022, 19932788.
19. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GY, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007, 9:1006-1023. 10.1093/europace/eum191, 17897925.